FREE Webinar
Wednesday, November 18, 2020
2:30 - 4:00 PM, Eastern Standard Time
Phenotypic screening identifies potential drug candidates based on their ability to modulate cells or organisms in a desired manner. However, phenotypic screening depends on models that can both induce pathological behavior and facilitate high throughput/high content screening. In this webinar from The Scientist, Molly Shoichet and Bridget Wagner will discuss strategies for creating such models and outline how they use them to identify agents to counter chronic diseases, such as cancer and diabetes.
Topics to be covered
Meet the Speakers:
Molly Shoichet, PhD, FRS, OC
Professor, Chemical Engineering & Applied Chemistry
Biomaterials & Biomedical Engineering
University of Toronto
Tier 1 Canada Research Chair in Tissue Engineering
Bridget Wagner, PhD
Director of Pancreatic Cell Biology and Metabolic Disease
Institute Scientist
Broad Institute of MIT and Harvard
Sponsored by
